| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.097 | 0.09 |